No influence of simvastatin treatment on platelet function in vivo in patients with hypercholesterolemia

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 2, 1997, Pages 273-278

  Bröijersén, Anders ^a   Eriksson, Mats ^a   Leijd, Barbro ^b   Angelin, Bo ^a   Hjemdahl, Paul ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b ST GÖRAN S HOSPITAL   (Sweden)

Author keywords

hyperlipoproteinemia; platelet function; simvastin; thromboxane; thromboglobulin

Indexed keywords

11 OXOTHROMBOXANE B2; BETA THROMBOGLOBULIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERCHOLESTEROLEMIA; MALE; MENTAL STRESS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; URINARY EXCRETION;

EID: 0031029341     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.2.273     Document Type: Article

References (17)

1. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 1992;326:242-250.
2. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 1992;326:310-318.
3. Carvalho ACA, Colman RW, Lees RS. Platelet function in hyperlipoproteinemia. N Engl J Med. 1974;290:434-438.
4. Schrör K, Löbel P, Steinhagen-Thiessen E. Simvastatin reduces platelet thromboxane formation and restores normal platelet sensitivity against prostacyclin in type Ha hypercholesterolemia. Eicosanoids. 1989;2:39-45.
5. Tremoli E, Madema P, Colli S, Morazzoni G, Sirtori M, Sirtori CR. Increased platelet sensitivity and thromboxane B2 formation in type-II hyperlipoproteinaemic patients. Eur J Clin Invest 1984;14:329-333.
6. Davi G, Averna M, Catalano I, Barbagallo C, Ganci A, Notarbartolo A, Ciabattoni G, Patrone C. Increased thromboxane biosynthesis in type Ha hypercholesterolemia. Circulation. 1992;85:1792-1798.
7. Zahavi J, Betteridge JD, Jones NAG, Galton DJ, Kakkar VV. Enhanced in vivo platelet release reaction and malondialdehyde formation in patients with hyperlipidemia. Am J Med. 1981;70:59-64.
8. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4s). Lancet. 1994;344:1383-1389.
9. 2 synthesis in type Ha hypercholesterolemic patients. Atherosclerosis. 1989;79:79-83.
10. Coumar A, Gill JK, Barradas MA, O'Donoghue S, Jeremy JY, Mikhailidis DP. The effect of treatment with simvastatin on platelet function indices in hypercholesterolaemia. J Drug Dev. 1991;4:79-86.
11. Notarbartolo A, Davì G, Averna M, Barbagallo CM, Ganci A, Giammarresi C, La Placa FP, Patrono C. Inhibition of thromboxane biosynthesis and platelet function by simvastatin in type IIa hypercholesterolemia. Arterioscler Thromb Vase Biol. 1995;15:247-251.
12. Willich SN, MacLure M, Mittleman M, Arntz H-R, Muller JE. Sudden cardiac death: support for a role of triggering in causation. Circulation. 1993;87:1442-1450.
13. Hjemdahl P, Larsson PT, Wallen NH. Effects of stress and β-blockade on platelet function. Circulation. 1991;84(suppl VI):VI-44-VI61.
14. Goldstein JL, Brown MS. Familial hypercholesterolemia. In: Scriver CR et al, eds. The Metabolic Basis of Inherited Disease. New York, NY: McGraw-Hill; 1989;1215-1250.
15. Grundy SM, Chait A, Brunzell JD. Familial combined hyperlipidemia workshop. Arteriosclerosis. 1987;7:203-207.
16. Frankenhaeuser M, Mellis I, Rissler A, Björkvall C, Patkai P. Catecholamine excretion as related to cognitive and emotional reaction patterns. Psychosoin Med. 1968;30:109-120.
17. Homstra G, ten Hoor F. The filtragometer: a new device for measuring platelet aggregation in venous blood of man. Thromb Diath Haemorrh. 1975;34:531-544.